Xcout Intel
CANCER GENETICS, INC competitors & alternatives
The 12 closest competitors and alternatives to CANCER GENETICS, INC among biotechnology companies — ranked by similarity to what CANCER GENETICS, INC actually does, not by market-cap band.
Subscribe to see CANCER GENETICS, INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CANCER GENETICS, INC
Cancer Genetics, Inc. is a biotechnology company headquartered in Rutherford, New Jersey, with operational history including facilities in Los Angeles, California. The company provides specialized oncology-focused diagnostic products, genomic services, and biomarker testing.
CANCER GENETICS, INC at a glance
CANCER GENETICS, INC is a biotechnology company headquartered in United States. It has raised at least $26.5M across the 4 funding rounds on record. Its most recent funding round raised $10M in February 2021.
CANCER GENETICS, INC funding rounds
At least $26.5M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10M | — | |
| SEC Form D filing | $6M | — | |
| SEC Form D filing | $5.5M | — | |
| SEC Form D filing | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 CANCER GENETICS, INC competitors
Ranked by semantic similarity — how close each company is to CANCER GENETICS, INC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
Biotech
NeoGenomics, Inc. is a specialized clinical laboratory company headquartered in Fort Myers, Florida. It operates a network of CAP-accredited and CLIA-certified laboratories to provide comprehensive oncology testing and sample processing services.
Biotech
Interpace Biosciences, Inc. is a U.S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system. This test, powered by the proprietary PathFinderTG platform, assists medical professionals in more accurately determining the risk of pancreaticobiliary cancers. It also offers PanDNA, a molecular-only variant of PancraGEN, which delivers insights into a select number of diagnostic markers. For thyroid health, the company provides ThyGeNEXT, an oncogenic mutation panel designed to identify malignant thyroid nodules. Additionally, ThyraMIR evaluates thyroid nodules for malignancy risk through the application of its proprietary microRNA gene-expression assay. Furthermore, RespriDx is a genomic diagnostic tool that aids clinicians in distinguishing between metastatic and recurrent lung cancer. Interpace Biosciences further supports the pharmaceutical and biotechnology sectors with services including pharmacogenomics testing, genotyping, biorepository solutions, and various custom scientific offerings. Its clientele primarily consists of physicians, hospitals, and clinics. Previously operating as Interpace Diagnostics Group, Inc., the company adopted its current name, Interpace Biosciences, Inc., in November 2019. Founded in 1986, its corporate headquarters are located in Parsippany, New Jersey.
Biotechnology & Medical Laboratories
Access Genetics LLC operates a national reference laboratory that provides personalized diagnostics and molecular DNA testing services, including salivary diagnostics through its OralDNA Labs division. The company serves healthcare clients and patients by offering comprehensive diagnostic test options and clinical lab services.
Similar biotechnology company
Matrix Genetics, LLC provides CLIA-certified hereditary cancer genetic testing, pharmacogenomics, and precision medicine services powered by AI. Based in a Chicago laboratory, the company offers a subscription-based health plan for individuals to assess cancer risks, match medications, and analyze DNA insights.
Similar biotechnology company
EcoGenome LLC is a biotechnology company that develops diagnostic tests and kits for cancer, specifically focusing on prostate cancer. The company identifies individual tumor genetic vulnerabilities to help inform precise therapy planning and treatment choices for patients.
Biotech
Invitae Corp. is a biotechnology company specializing in genetic testing and laboratory services. The firm has operated with a significant operational footprint and experienced corporate acquisitions within the healthcare market.
Biotech
Gene Solutions LLC provides AI-powered genetic testing and multi-dimensional genomics services focused on oncology and reproductive health. The company offers blood-based early cancer detection tests, tumor profiling, and minimal residual disease monitoring for patients and healthcare providers.
Biotech
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Life Sciences
Pathwork Diagnostics developed molecular diagnostic tests for cancer, notably the Tissue of Origin test, which analyzes tumor gene-expression patterns to help identify the likely primary site of metastatic cancers when the origin is unknown. Its products served pathologists and oncologists managing patients with cancers of unknown primary.
Biotech
Cofactor Genomics develops RNA-Seq technology and predictive diagnostics to help match cancer patients with appropriate immunotherapy treatments. The company offers tools such as the OncoPrism assay and collaborates with healthcare systems and clinical researchers to evaluate multidimensional biomarkers for various solid tumor cancers.
Biotech
Centogene provides precision medicine solutions through advanced diagnostics, multiomic testing, and bioinformatics platforms. The company serves physicians, patients, and pharmaceutical partners by offering genomic sequencing, biomarker testing, and data-driven insights to accelerate rare disease diagnosis, drug discovery, and personalized therapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CANCER GENETICS, INC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CANCER GENETICS, INCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →